Upon biological evaluation, five out of the initially tested 20 hits exhibited positive activities to form direct binding to GAB1 PH domain, inhibit GAB1 Y627 phosphorylation and suppress breast cancer cell proliferation with low micromolar IC50. The gene discussed is GAB1; the disease is breast carcinoma.